Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection - Correlation with clinical progression, viral load, and loss of humoral immunity

Virology

Volumn 238, Issue 2, 1997, Pages 180-188

  Samuelsson, Astrid ^a   Broström, Christina ^b   Van Dijk, Nienke ^a   Sönnerborg, Anders ^b   Chiodi, Francesca ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; B cells; CD4+ T cells; HIV 1 infection; Neutralization; Viral load

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; NEUTRALIZING ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY TITER; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS PATHOGENESIS;

EID: 0031585551     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8790     Document Type: Article

References (43)

1. Albert J., Abrahamsson B., Nagy K., Aurelius E., Gaines H., Nyström G., Fenyö E. M. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS. 4:1990;107-112.
2. Andrieu J. M., Lu W., Levy R. Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. J. Infect. Dis. 171:1995;523-530.
3. Berberian L., Valles-Ayoub Y., Sun N., Martinez-Maza O., Braun J. A VH clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest. Blood. 78:1991;175-179.
4. Bilello J. A., Stellrecht K., Drusano G. L., Stein D. S. Soluble tumor necrosis factor-alpha receptor type II (sTNF-alpha-RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J. Infect. Dis. 173:1996;464-467.
5. Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T., Thompson C. B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 3:1995;87-98.
6. Buchbinder S. P., Katz M. H., Hessol N. A., O'Malley P. M., Holmberg S. D. Long-term HIV-1 infection without immunologic progression. AIDS. 8:1994;1123-1128.
7. Buhl R., Jaffe H. A., Holroyd K. J., Wells F. B., Mastrangeli A., Saltini C., Cantin A. M., Crystal R. G. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 2:1989;1294-1298.
8. Cao Y., Qin L., Zhang L., Safrit J., Ho D. D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:1995;201-208.
9. Carbonari M., Cibati M., Cherchi M., Sbarigia D., Pesce A. M., Dell'Anna L., Modica A., Fiorilli M. Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood. 83:1994;1268-1277.
10. Carroll R. G., Riley J. L., Levine B. L., Feng Y., Kaushal S., Ritchey D. W., Bernstein W., Weislow O. S., Brown C. R., Berger E. A., June C. H., Stlouis D. C. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4(+) T cells. Science. 276:1997;273-276.
11. Dean M., Carrington M., Goedert J., O'brien S. J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 274:1996;1069.
12. Estaquier J., Idziorek T., De Bels F., Barré-Sinoussi F., Hurtrel B., Aubertin A.-M., Venet A., Mehtali M., Muchmore E., Michel P., Mouton Y., Girard M., Ameisen J. C. Programmed cell death and AIDS: Significance of apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc. Natl. Acad. Sci. USA. 91:1994;9431-9435.
13. ++. Blood. 87:1996;4959-4966.
14. Glynn J. M., McElligott D. L., Mosier D. E. Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist. J. Immunol. 157:1996;2754-2758.
15. Gougeon M.-L., Garcia S., Heeney J., Tschopp R., Lecoeur H., Guetard D., Rame V., Dauguet C., Montagnier L. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retroviruses. 9:1993;553-563.
16. +. J. Exp. Med. 175:1992;331-340.
17. Gummuluru S., Novembre F. J., Lewis M., Gelbard H. A., Dewhurst S. Apoptosis correlates with immune activation in intestinal lymphoid tissue from macaques acutely infected by a highly enteropathic simian immunodeficiency virus, SIVsmmpbj14. Virology. 225:1996;21-32.
18. Hammer S. M. Advances in antiretroviral therapy and viral load monitoring. AIDS. 10:1996;S1-11.
19. Harrer T., Harrer E., Kalams S. A., Elbeik T., Staprans S. I., Feinberg M., Cao Y., Ho D. D., Yilma T., Caliendo A. M., Johnson R. P., Buchbinder S. P., Walker B. D. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses. 12:1996;585-592.
20. Haynes B. F., Pantaleo G., Fauci A. S. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 271:1996;324-328.
21. Herzenberg L. A., De Rosa S. C., Dubs J. G., Roederer M., Anderson M. T., Ela S. W., Deresinski S. C., Herzenberg L. A. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. USA. 94:1997;1967-1972.
22. Huang Y. X., Paxton W. A., Wolinsky S. M., Neumann A. U., Zhang L. Q., He T., Kang S., Ceradini D., Jin Z. Q., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N. R., Phair J., Ho D. D., Koup R. A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2:1996;1240-1243.
23. Katsikis P. D., Wunderlich E. S., Smith C. A., Herzenberg L. A., Herzenberg L. A. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:1995;2029-2036.
24. Kirchhoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:1995;228-232.
25. Koopman G., Reutelingsperger C. P., Kuijten G. A., Keehnen R. M., Pals S. T., van Oers M. H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
26. Learmont J., Tindall B., Evans L., Cunningham A., Cunningham P., Wells J., Penny R., Kaldor J., Cooper D. A. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet. 340:1992;863-867.
27. Levine B. L., Mosca J. D., Riley J. L., Carroll R. G., Vahey M. T., Jagodzinski L. L., Wagner K. F., Mayers D. L., Burke D. S., Weislow O. S., Stlouis D. C., June C. H. Antiviral effect and ex vivo CD4(+) T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science. 272:1996;1939-1943.
28. Meyaard L., Otto S. A., Jonker R. R., Mijnster M. J., Keet R. P., Miedema F. Programmed death of T cells in HIV-1 infection. Science. 257:1992;217-219.
29. Meyaard L., Otto S. A., Keet I. P., Roos M. T., Miedema F. Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J. Clin. Invest. 93:1994;982-988.
30. Michael N. L., Chang G., d'Arcy L. A., Ehrenberg P. K., Mariani R., Busch M. P., Birx D. L., Schwartz D. H. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J. Virol. 69:1995;4228-4236.
31. Montefiori D. C., Pantaleo G., Fink L. M., Zhou J. T., Zhou J. Y., Bilska M., Miralles G. D., Fauci A. S. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J. Infect. Dis. 173:1996;60-67.
32. Muro-Cacho C. A., Pantaleo G., Fauci A. S. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154:1995;5555-5566.
33. Nicoletti I., Migliorati G., Pagliacci M. C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
34. Pandolfi F., Pierdominici M., Oliva A., D'Offizi G., Mezzaroma I., Mollicone B., Giovannetti A., Rainaldi L., Quinti I., Aiuti F. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J. Acquired Immune Defic. Syndromes Hum. Retrovirol. 9:1995;450-458.
35. Pantaleo G., Menzo S., Vaccarezza M., Graziosi C., Cohen O. J., Demarest J. F., Montefiori D., Orenstein J. M., Fox C., Schrager L. K., Margolick J. B., Buchbinder S., Giorgi J. V., Fauci A. S. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:1995;209-216.
36. Rinaldo C., Huang X. L., Fan Z. F., Ding M., Beltz L., Logar A., Panicali D., Mazzara G., Liebmann J., Cottrill M. et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:1995;5838-5842.
37. Rizzardi G. P., Barcellini W., Tambussi G., Lillo F. Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection - Correlation with HIV-1 RNA and the clinical outcome. AIDS. 10:1996;50.
38. Samuelsson A., Sönnerborg A., Heuts N., Cöster J., Chiodi F. Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses. 13:1997;1031-1038.
39. Scarlatti G., Albert J., Rossi P., Hodara V., Biraghi P., Muggiasca L., Fenyo E. M. Mother-to-child transmission of human immunodeficiency virus type 1: Correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 168:1993;207-210.
40. Schuitemaker H., Meyaard L., Kootstra N. A., Dubbes R., Otto S. A., Tersmette M., Heeney J. L., Miedema F. Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J. Infect. Dis. 168:1993;1140-1147.
41. +. AIDS. 7:1993;1159-1166.
42. Sundqvist V. A., Albert J., Ohlsson E., Hinkula J., Fenyo E. M., Wahren B. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J. Med. Virol. 29:1989;170-175.
43. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.